Author

Kristin Coffan

Institution: Children's Hospital of Philadelphia

Observed institutions: Children's Hospital of Philadelphia, Eastern Cooperative Oncology Group, Abramson Cancer Center, University of Pennsylvania

OpenAlex ID: A5083159737

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia

2021 · Anjali S. Advani, Eric Larsen, et al. · Blood Advances · 55

Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance)

2013 · Anjali S. Advani, Ben Sanford, et al. · Blood · 47

Outcomes of children and young adults with T‐cell acute lymphoblastic leukemia/lymphoma who present in critical status

2022 · Nicole J. Wayne, Yimei Li, et al. · Pediatric Blood & Cancer · 5

Sirolimus Plus MEC Chemotherapy Has Significant Activity in High Risk AML Patients Especially Those Who Exhibit in Vivo Inhibition of the mTOR Pathway

2012 · Margaret Kasner, Mark Weiss, et al. · Blood · 3

Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL)

2012 · Lori S. Muffly, Wendy Stock, et al. · Blood · 1

Works count: 5

Citation count: 111

H-index: 3

I10-index: 2